Abstract
Pulmonary embolism (PE) most often occurs in the setting of lower extremity deep venous thrombosis (DVT) and is a major contributor to morbidity and mortality worldwide. First-line therapy is systemic anticoagulation (AC). In patients who cannot be therapeutically anticoagulated, inferior vena cava (IVC) filters can be placed to provide mechanical clot filtration to prevent PE in the setting of DVT. First introduced in the 1960s, IVC filters have evolved into low-profile devices, which can be deployed percutaneously. A variety of models are available on the market today, including many optional devices, which can be retrieved once the period of venothromboembolism (VTE) risk has elapsed. Standard technique for IVC filter retrieval includes the use of endovascular snares; however, alternative methods such as endobronchial forceps or laser sheath ablation may be needed in complicated cases. Studies have shown the efficacy of IVC filters for reducing the risk of recurrent symptomatic PE but have also revealed an increased risk for DVT and clot propagation. Additionally, there has been increasing recognition of device-related complications, including filter migration, fracture, and penetration through the IVC wall, which can lead to significant clinical sequelae. Consequently, it is essential to place IVC filters in appropriately selected patients and provide vigilant follow-up to remove the filters as soon as clinically indicated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464–74.
Grosse SD, Nelson RE, Nyarko KA, Richardson LC, Raskob GE. The economic burden of incident venous thromboembolism in the United States: a review of estimated attributable healthcare costs. Thromb Res. 2016;137:3–10.
Stevens SM, Woller SC, Kreuziger LB, Bounameaux H, Doerschug K, Geersing GJ, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021;160(6):e545–608.
Mobin-Uddin K, Callard GM, Bolooki H, Rubinson R, Michie D, Jude JR. Transvenous caval interruption with umbrella filter. N Engl J Med. 1972;286(2):55–8.
Wingerd M, Bernhard VM, Maddison F, Towne JB. Comparison of caval filters in the management of venous thromboembolism. Arch Surg. 1978;113(11):1264–71.
Greenfield LJ, Zocco J, Wilk J, Schroeder TM, Elkins RC. Clinical experience with the Kim-Ray Greenfield vena caval filter. Ann Surg. 1977;185(6):692–8.
Johnson MS, Nemcek AA Jr, Benenati JF, Baumann DS, Dolmatch BL, Kaufman JA, et al. The safety and effectiveness of the retrievable option inferior vena cava filter: a United States prospective multicenter clinical study. J Vasc Interv Radiol. 2010;21(8):1173–84.
Le Blanche AF, Ricco JB, Bonneau M, Reynaud P. The optional VenaTech() convertible () vena cava filter: experimental study in sheep. Cardiovasc Intervent Radiol. 2012;35(5):1181–7.
Lyon SM, Riojas GE, Uberoi R, Patel J, Lipp ME, Plant GR, et al. Short- and long-term retrievability of the Celect vena cava filter: results from a multi-institutional registry. J Vasc Interv Radiol. 2009;20(11):1441–8.
Smouse HB, Rosenthal D, Thuong VH, Knox MF, Dixon RG, Voorhees WD 3rd, et al. Long-term retrieval success rate profile for the Gunther Tulip vena cava filter. J Vasc Interv Radiol. 2009;20(7):871–7; quiz 8.
Stavropoulos SW, Chen JX, Sing RF, Elmasri F, Silver MJ, Powell A, et al. Analysis of the final DENALI trial data: a prospective, multicenter study of the Denali inferior vena cava filter. J Vasc Interv Radiol. 2016;27(10):1531–8 e1.
Ziegler JW, Dietrich GJ, Cohen SA, Sterling K, Duncan J, Samotowka M. PROOF trial: protection from pulmonary embolism with the OptEase filter. J Vasc Interv Radiol. 2008;19(8):1165–70.
Mismetti P, Rivron-Guillot K, Quenet S, Decousus H, Laporte S, Epinat M, et al. A prospective long-term study of 220 patients with a retrievable vena cava filter for secondary prevention of venous thromboembolism. Chest. 2007;131(1):223–9.
Dake MD, Murphy TP, Kramer AH, Darcy MD, Sewall LE, Curi MA, et al. Final two-year outcomes for the sentry bioconvertible inferior vena cava filter in patients requiring temporary protection from pulmonary embolism. J Vasc Interv Radiol. 2020;31(2):221–30 e3.
Kaufman JA, Barnes GD, Chaer RA, Cuschieri J, Eberhardt RT, Johnson MS, et al. Society of Interventional Radiology Clinical Practice Guideline for inferior vena cava filters in the treatment of patients with venous thromboembolic disease: developed in collaboration with the American College of Cardiology, American College of Chest Physicians, American College of Surgeons Committee on trauma, American Heart Association, Society for Vascular Surgery, and Society for Vascular Medicine. J Vasc Interv Radiol. 2020;31(10):1529–44.
Angel LF, Tapson V, Galgon RE, Restrepo MI, Kaufman J. Systematic review of the use of retrievable inferior vena cava filters. J Vasc Interv Radiol. 2011;22(11):1522–30 e3.
Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard P, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med. 1998;338(7):409–15.
Group PS. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study. Circulation. 2005;112(3):416–22.
White RH, Brunson A, Romano PS, Li Z, Wun T. Outcomes after vena cava filter use in noncancer patients with acute venous thromboembolism: a population-based study. Circulation. 2016;133(21):2018–29.
US Food and Drug Administration. Inferior Vena Cava (IVC) filters: initial communication. Risk of adverse events with long term use 2010 [updated August 9, 2010]. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm221707.htm.
US Food and Drug Administration. Removing retrievable inferior vena cava filters: FDA Safety Communication 2014 [updated May 6, 2014]. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm396377.htm.
Ahmed O, Wadhwa V, Patel K, Patel MV, Turba UC, Arslan B. Rising retrieval rates of inferior vena cava filters in the United States: insights from the 2012 to 2016 summary medicare claims data. J Am Coll Radiol. 2018;15(11):1553–7.
Karp JK, Desai KR, Salem R, Ryu RK, Lewandowski RJ. A dedicated inferior vena cava filter service line: how to optimize your practice. Semin Intervent Radiol. 2016;33(2):105–8.
Winters JP, Morris CS, Holmes CE, Lewis P, Bhave AD, Najarian KE, et al. A multidisciplinary quality improvement program increases the inferior vena cava filter retrieval rate. Vasc Med. 2016;22:51.
Ray CE Jr, Mitchell E, Zipser S, Kao EY, Brown CF, Moneta GL. Outcomes with retrievable inferior vena cava filters: a multicenter study. J Vasc Interv Radiol. 2006;17(10):1595–604.
Iliescu B, Haskal ZJ. Advanced techniques for removal of retrievable inferior vena cava filters. Cardiovasc Intervent Radiol. 2012;35(4):741–50.
Stavropoulos SW, Ge BH, Mondschein JI, Shlansky-Goldberg RD, Sudheendra D, Trerotola SO. Retrieval of tip-embedded inferior vena cava filters by using the endobronchial forceps technique: experience at a single institution. Radiology. 2015;275(3):900–7.
Kuo WT, Doshi AA, Ponting JM, Rosenberg JK, Liang T, Hofmann LV. Laser-assisted removal of embedded vena cava filters: a first-in-human escalation trial in 500 patients refractory to high-force retrieval. J Am Heart Assoc. 2020;9(24):e017916.
Kesselman AJ, Hoang NS, Sheu AY, Kuo WT. Endovascular removal of fractured inferior vena cava filter fragments: 5-year registry data with prospective outcomes on retained fragments. J Vasc Interv Radiol. 2018;29(6):758–64.
Puller HF, Stavropoulos SW, Trerotola SO. Stability of retained inferior vena cava filter fragments after filter removal. J Vasc Interv Radiol. 2021;32(10):1457–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chen, J.X., Stavropoulos, S.W. (2024). IVC Filters. In: Keefe, N.A., Haskal, Z.J., Park, A.W., Angle, J.F. (eds) IR Playbook. Springer, Cham. https://doi.org/10.1007/978-3-031-52546-9_12
Download citation
DOI: https://doi.org/10.1007/978-3-031-52546-9_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-52545-2
Online ISBN: 978-3-031-52546-9
eBook Packages: MedicineMedicine (R0)